1832 Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.2M Sell
616,840
-554,796
-47% -$64.1M 0.07% 192
2025
Q4
$123M Buy
1,171,636
+518,231
+79% +$48.6M 0.09% 146
2025
Q3
$54.8M Buy
653,405
+99,621
+18% +$8.21M 0.04% 192
2025
Q2
$43.8M Buy
553,784
+77,646
+16% +$6.17M 0.03% 205
2025
Q1
$42.7M Sell
476,138
-15,376
-3% -$1.44M 0.04% 213
2024
Q4
$48.9M Buy
491,514
+436,641
+796% +$45M 0.04% 189
2024
Q3
$6.23M Buy
54,873
+3,504
+7% +$416K ﹤0.01% 380
2024
Q2
$6.36M Buy
51,369
+1,247
+2% +$161K 0.01% 363
2024
Q1
$6.61M Sell
50,122
-3,954
-7% -$487K ﹤0.01% 360
2023
Q4
$5.9M Sell
54,076
-245,317
-82% -$25.5M 0.01% 370
2023
Q3
$30.8M Sell
299,393
-1,705,656
-85% -$184M 0.04% 211
2023
Q2
$231M Sell
2,005,049
-736,184
-27% -$83.6M 0.27% 59
2023
Q1
$292M Sell
2,741,233
-758,840
-22% -$81.9M 0.42% 42
2022
Q4
$388M Sell
3,500,073
-256,737
-7% -$26.2M 0.65% 33
2022
Q3
$324M Sell
3,756,810
-375,876
-9% -$33.6M 0.6% 41
2022
Q2
$377M Buy
4,132,686
+4,053,991
+5,152% +$359M 0.66% 36
2022
Q1
$6.37M Sell
78,695
-36,293
-32% -$2.86M 0.01% 430
2021
Q4
$8.94M Sell
114,988
-161,079
-58% -$12.8M 0.02% 321
2021
Q3
$20.9M Buy
276,067
+167,975
+155% +$12.8M 0.04% 259
2021
Q2
$8.41M Sell
108,092
-63,161
-37% -$4.7M 0.02% 335
2021
Q1
$12.5M Sell
171,253
-544,291
-76% -$40.1M 0.03% 273
2020
Q4
$54.8M Sell
715,544
-2,628,323
-79% -$201M 0.13% 150
2020
Q3
$263M Sell
3,343,867
-455,551
-12% -$35.7M 0.69% 45
2020
Q2
$278M Buy
3,799,418
+2,756,911
+264% +$208M 0.83% 31
2020
Q1
$76.6M Sell
1,042,507
-238,650
-19% -$18.8M 0.28% 87
2019
Q4
$112M Buy
1,281,157
+998,934
+354% +$82M 0.34% 75
2019
Q3
$22.3M Buy
282,223
+2,214
+0.8% +$177K 0.07% 176
2019
Q2
$22.2M Buy
280,009
+137,233
+96% +$10.5M 0.07% 180
2019
Q1
$11.1M Sell
142,776
-100,709
-41% -$7.53M 0.04% 219
2018
Q4
$17.5M Sell
243,485
-154,098
-39% -$10.9M 0.07% 179
2018
Q3
$26.8M Buy
397,583
+6,921
+2% +$441K 0.09% 160
2018
Q2
$22.9M Sell
390,662
-216,820
-36% -$12.2M 0.08% 169
2018
Q1
$31.5M Sell
607,482
-399,778
-40% -$21.6M 0.12% 147
2017
Q4
$53.6M Sell
1,007,260
-1,568,601
-61% -$87M 0.17% 119
2017
Q3
$153M Buy
2,575,861
+556,102
+28% +$33.7M 0.54% 52
2017
Q2
$123M Buy
2,019,759
+326,376
+19% +$19.9M 0.56% 46
2017
Q1
$103M Sell
1,693,383
-1,496,457
-47% -$90.8M 0.37% 68
2016
Q4
$182M Buy
3,189,840
+1,811,899
+131% +$106M 0.31% 84
2016
Q3
$82.1M Buy
1,377,941
+801,618
+139% +$46.9M 0.31% 82
2016
Q2
$31.8M Buy
576,323
+2,189
+0.4% +$117K 0.12% 157
2016
Q1
$44.5M Buy
574,134
+455,064
+382% +$22.3M 0.11% 159
2015
Q4
$6.01M Sell
119,070
-29,623
-20% -$1.49M 0.03% 276
2015
Q3
$7.03M Sell
148,693
-621,009
-81% -$33M 0.03% 261
2015
Q2
$41.6M Buy
769,702
+584,048
+315% +$32.8M 0.14% 150
2015
Q1
$10.2M Sell
185,654
-1,451,644
-89% -$82.2M 0.04% 230
2014
Q4
$88.3M Buy
1,637,298
+252,853
+18% +$14.1M 0.27% 89
2014
Q3
$78.1M Sell
1,384,445
-286,284
-17% -$16.1M 0.26% 104
2014
Q2
$92.1M Buy
1,670,729
+348,559
+26% +$19M 0.29% 90
2014
Q1
$70.7M Buy
1,322,170
+925,418
+233% +$47.9M 0.24% 106
2013
Q4
$18.9M Buy
396,752
+383,966
+3,003% +$17.6M 0.07% 197
2013
Q3
$580K Sell
12,786
-335,758
-96% -$15.3M ﹤0.01% 351
2013
Q2
$15.4M Buy
+348,544
New +$15.6M 0.07% 190

Other funds holding MRK

1832 Asset Management's MRK Position: Q1 2026 in Review

1832 Asset Management reduced its Merck (MRK) stake by 47% in Q1 2026, selling an estimated $64.1M and leaving 616,840 shares worth $74.2M. The position accounts for 0.07% of the portfolio, ranked #192.

1832 Asset Management first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $388M in Q4 2022. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • 1832 Asset Management held 616,840 shares of Merck worth $74.2M as of Q1 2026.
  • 1832 Asset Management sold 554,796 Merck shares in Q1 2026, an estimated $64.1M.
  • Merck made up 0.07% of 1832 Asset Management's portfolio in Q1 2026, its #192 holding.
  • 1832 Asset Management first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 1832 Asset Management's Merck position peaked at $388M in Q4 2022.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on 1832 Asset Management's 13F filing for Q1 2026, filed 14 May 2026.